Clinical trial
Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus
NCT00133107 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00133107 |
|---|---|
| Title | Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus |
| Official title | A Single Center, Open-label, Pilot Study Evaluating the Safety and Effectiveness of Subcutaneous Efalizumab in the Treatment of Oral Lichen Planus |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lichen Planus, Oral |
| Intervention type | Drug |
| Interventions | efalizumab |
| Enrollment | 4 |
| Start date | Jan 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Aug 22, 2005 |
| Last update posted | Aug 19, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: